-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Crofelemer DR in Irritable Bowel Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crofelemer DR in Irritable Bowel Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crofelemer DR in Irritable Bowel Syndrome Drug Details: Crofelemer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Crofelemer DR in Cholera
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crofelemer DR in Cholera report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crofelemer DR in Cholera Drug Details: Crofelemer (Fulyzaq, Mytesi) is an anti...
-
Product Insights
Guangxi Baise Napo Yangjiashan Wind Farm
Guangxi Baise Napo Yangjiashan Wind Farm is an Onshore Wind project located in Guangxi Zhuang Autonomous Region, China. The project is owned and developed by China Huaneng Group Co Ltd. The project came online in 2023. Empower your strategies with our Guangxi Baise Napo Yangjiashan Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewShort Bowel Syndrome – Drugs In Development, 2024
Empower your strategies with our Short Bowel Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness, and diarrhea. Complications of short bowel syndrome include malnutrition, peptic ulcers, kidney stones, and small intestinal bacterial overgrowth. Treatment includes vitamin and mineral supplements, antibiotics,...
-
Product Insights
NewDiarrhea – Drugs In Development, 2024
Empower your strategies with our Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. The Diarrhea drugs in development market research report...
-
Product Insights
NewInfectious Diarrhea – Drugs In Development, 2024
Empower your strategies with our Infectious Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Infectious Diarrhea is a common gastrointestinal infection and the most common type of diarrhea. Diarrhea is defined as frequent bowel movements that are loose, watery, and associated with nausea, vomiting, and fatigue. Bacterial, viral, and protozoans are the common pathogens leading to infectious diarrhea. E. coli-associated infections are the most common bacteria while Entamoeba histolytica is a common parasite causing infectious diarrhea....
-
Product Insights
NewChemotherapy-Induced Diarrhea (CID) – Drugs In Development, 2024
Empower your strategies with our Chemotherapy-Induced Diarrhea (CID) – Drugs In Development, 2024 report and make more profitable business decisions. Chemotherapy-induced diarrhea (CID) is a common problem in patients with advanced cancer. The incidence of CID has been reported to be as high as 50-80% of treated patients, especially those treated with a 5-fluorouracil bolus or some combination therapies of irinotecan and fluoropyrimidines. Regardless of the molecular targeted approach of tyrosine kinase inhibitors and antibodies, diarrhea is a common side effect...
-
Product Insights
NewCholera – Drugs In Development, 2024
Empower your strategies with our Cholera – Drugs In Development, 2024 report and make more profitable business decisions. Cholera is an acute infectious disease caused by a bacterium, Vibrio cholera, which results in a painless, watery diarrhea in humans. Symptoms of cholera can begin as soon as a few hours or as long as five days after infection. Symptoms are often mild, they can be very serious. Signs and symptoms of cholera include rapid heart rate, loss of skin elasticity, low...
-
Product Insights
NewTraveler’s Diarrhea – Drugs In Development, 2024
Empower your strategies with our Traveler's Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Traveler's diarrhea occurs within 10 days of travel to an area with poor public hygiene. The most common illness in travelers, it is caused by drinking water or eating food that contains bacteria, viruses, or parasites. Most traveler's diarrhea is from bacteria. It often goes away in a few days. Often, the only treatment is fluid replacement. The Traveler's Diarrhea drugs in...
-
Product Insights
NewIrritable Bowel Syndrome – Drugs In Development, 2024
Empower your strategies with our Irritable Bowel Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects the large intestine (colon). Symptoms include cramping, abdominal pain, bloating gas, diarrhea, backache, muscle pains, poor appetite, and constipation. These symptoms can be triggered by food, stress, and hormones. Risk factors include age and family history. Treatment includes anti-diarrheal, anticholinergic, antidepressant, and antibiotic medications. The Irritable Bowel Syndrome drugs in...